Filing Flows › Comparisons › ASPI vs PURE
ASP Isotopes vs Pure Bioscience: ASPI and PURE compared
ASP Isotopes is the larger company: $5.1M of revenue in its latest quarter (Q2 2026) against $659K for Pure Bioscience (Q4 FY26). ASP Isotopes is growing faster (+328% against -14% a year earlier). Pure Bioscience is more profitable, with an operating margin of -76.3% against -667.5%.
Where the money goes: ASPI and PURE
ASP Isotopes (ASPI) · Q2 2026
ASP Isotopes, Q2 2026: revenue $5.1M (+328% year over year), operating margin -667.5%, net loss $34.0M, operating cash flow −$23.3M. The chart follows the revenue to costs, profit and cash.
Pure Bioscience (PURE) · Q4 FY26
Pure Bioscience, Q4 FY26: revenue $659K (-14% year over year), operating margin -76.3%, net loss $610K, operating cash flow −$414K. The chart follows the revenue to costs, profit and cash.
| ASP Isotopes (ASPI) | Pure Bioscience (PURE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 FY26 |
| Revenue | $5.1M | $659K |
| Revenue growth, Y/Y | +328% | -14% |
| Operating margin | -667.5% | -76.3% |
| Net earnings | −$34.0M | −$610K |
| Net margin | -663.5% | -92.6% |
| Operating cash flow | −$23.3M | −$414K |
Where the revenue comes from
ASP Isotopes
- Product: $4.5M (88%)
- Collaboration Revenue: $600K (12%)
Pure Bioscience
- Product: $659K (100%)
- Royalty: $1K (0%)
Questions
Which is bigger, ASP Isotopes or Pure Bioscience?
ASP Isotopes is the larger company: $5.1M of revenue in its latest quarter (Q2 2026) against $659K for Pure Bioscience (Q4 FY26).
Is ASP Isotopes or Pure Bioscience growing faster?
ASP Isotopes is growing faster (+328% against -14% a year earlier).
Which is more profitable, ASP Isotopes or Pure Bioscience?
Pure Bioscience is more profitable, with an operating margin of -76.3% against -667.5%.
More: ASP Isotopes earnings · how ASP Isotopes makes money · Pure Bioscience earnings · how Pure Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-K filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.